|Bid||0.00 x 800|
|Ask||189.45 x 900|
|Day's Range||171.79 - 173.94|
|52 Week Range||146.68 - 190.36|
|PE Ratio (TTM)||13.63|
|Earnings Date||Oct 23, 2018 - Oct 29, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||198.33|
One of the Triad's most prominent family homes has returned to its family. Caroline Corp. of Burlington, controlled by Dr. James Powell III, bought Powell Manor at 2400 York Road in Burlington from Elon University for $1,086,500. Built in 1964 on almost three acres by Powell's parents, the late James Powell Jr. and Annabelle Council Powell, the home was bequeathed to Elon after the death of Powell III's sister, Annabelle "Beth" Powell, in 2017.
LabCorp® (LH) announced today that for the period of September 11, 2018 to March 8, 2019, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended September 6, 2018, in addition to the continued accrual of the original issue discount. Contingent cash interest, which the Company has determined to be approximately $2.89 per Note, will be payable to holders of the Zero Coupon Notes as of the record date, which is February 22, 2019. The payment of contingent cash interest is expected to be made on March 8, 2019.
LabCorp® (LH) today announced it will participate at the Morgan Stanley Global Healthcare Conference. LabCorp’s presentation is planned for Thursday, September 13, 2018 at 2:05 pm (ET). A live audio webcast will be available via the Company website at www.labcorp.com and archived for replay.
The blood-testing company, based most of its life in Palo Alto, has faced lawsuits from investors, the SEC and criminal charges against founder and former CEO Elizabeth Holmes and former President Ramesh "Sunny" Balwani.
Considering the rising popularity of PBM, CRO and EHR in the U.S. Medical Services industry, these three picks might be money-spinning choices for investors.
Let’s talk about the popular Laboratory Corporation of America Holdings (NYSE:LH). The company’s shares saw its share price hover around a small range of $172.59 to $189.41 over the lastRead More...
Nearly one in nine men, one in six African-American men, will be diagnosed with prostate cancer BOCA RATON, Fla. , Aug. 16, 2018 /PRNewswire/ -- Prostate cancer is the second most common cancer among men. ...
Durham County approved incentives worth nearly $450,000 combined Monday, including a package solidifying gene therapy firm AveXis’ 200-job expansion in the Triangle.
The acquisition of Covance Food Solutions by a European firm from Burlington-based LabCorp (LH: NYSE) is final. The $670 million deal, which Triad Business Journal reported in April, transfers ownership of the food testing company to Eurofins Scientific, a bioanaylitical testing firm located in Luxembourg. Eurofins Scientific (EUFI: PA) CEO Giles Martin said the opportunity to acquire such a high quality asset as Covance represents a clear milestone for his firm, pushing it further along in its goal toward building a testing platform with ”world-class infrastructure, science and IT solutions” by 2020. The business provides laboratory testing and consulting services for food and beverage products, and became a part of LabCorp when the Burlington-based company acquired Covance in 2015.
LabCorp's (LH) Covance Drug Development business has reported sturdy growth on strategic acquisitions, robust organic growth and a positive foreign currency translation.
LabCorp (LH) delivered earnings and revenue surprises of 2.05% and 0.59%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
NEW YORK, July 25, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Clearwater ...
The Burlington, North Carolina-based company said it had net income of $2.27 per share. Earnings, adjusted for amortization costs and restructuring costs, were $2.98 per share. The results beat Wall Street ...
NEW YORK, NY / ACCESSWIRE / July 25, 2018 / Laboratory Corporation of America Holdings (NYSE: LH ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 25, 2018 at 9:00 ...
BURLINGTON, N.C.-- -- Q2 revenue of $2.9 billion, up 13% over $2.5 billion last year Q2 diluted EPS of $2.27, up 28% from $1.78 last year; Q2 adjusted EPS of $2.98, up 23% over $2.43 last year Q2 free cash flow of $280 million, up 16% over $241 million last year 2018 adjusted EPS guidance of $11.35 to $11.65, up 23% to 26% over 2017 2018 free cash flow guidance of $1.1 billion to $1.2 billion LabCorp ...
Laboratory of America (NYSE: LH ) releases its next round of earnings Wednesday. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report. Earnings and Revenue Sell-side ...
The Medical product market further gains momentum on the back of a recent two-year suspension of the controversial 2.3% Medical Device tax.
The medical-testing giant Laboratory Corp. of America is dealing with a broad cyberattack, people familiar with the matter said, the latest breach to disrupt companies that hold sensitive information. The company, known as LabCorp, has said it was investigating suspicious activity but hasn’t previously disclosed publicly the nature or extent of the “ransomware” attack. It hit one of the company’s genetic-testing units over the weekend, and the impact spread in the ensuing days, the people said.
LabCorp has said that the 'suspicious activity' detected over the weekend was an attack by a 'new variant of ransomware.'